Qvents
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Individual
Company
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Archives:
News
Akorn USA Issues recall of various Human
Qvents
April 29, 2023
Sun Pharma has received a USFDA Consent
Qvents
April 28, 2023
USFDAÂ had declined to approve Eli Lill
Qvents
April 18, 2023
FDA Announce Decision to Withdraw Approv
Qvents Team
April 18, 2023
FDA issues draft Guidance on Notifying F
Qvents Team
April 9, 2023
Pharming
Qvents Team
April 9, 2023
USFDA inspected Global Pharma facility f
” target=”_blank”>Read More..</a>
Qvents Team
March 31, 2023
Pfizer Recalls 4.2 Mln Units Of Nurtec O
Qvents Team
March 20, 2023
Pfizer to acquire Seagen for $43 billion
Qvents Team
March 18, 2023
US FDA confirms the safety of Titanium d
Qvents Team
March 2, 2023
1
…
23
24
25
Facebook
LinkedIn
Twitter
Search Posts
Latest Posts
Nitrosamine Impurities in Pharmaceutical Products: Templates for Risk Assessment and Supplier Evaluation
June 28, 2025
Supply Chain Traceability of Medicinal Products
May 31, 2025
Continuous Process Verification (CPV) and Evaluation Templates
May 16, 2025
Concerns of Beta-lactam Contamination Triggers Massive Recall by Glenmark
April 28, 2025
Excipient Risk Assessment: Approach, Templates
April 24, 2025